Crimson's Strategy

Crimson's acquire-develop-commercialize model can offer significant advantages to both oversea and local partners. On one hand, Crimson can address the region's growing demand for new products and provide local patients earlier access to world-class novel therapeutics. On the other hand, through expedited pre-clinical and clinical studies, Crimson can generate invaluable clinical and market data earlier, and offer powerful commercialization strategies to push products to market more quickly. As a result, Crimson's global partners can enjoy accelerated development programs, prolonged market exclusivity in the region, and potentially a cost-effective manufacturing solution for the global market as well. A win-win partnership indeed.